|
Volumn 20, Issue 3, 2010, Pages 400-401
|
Morphea, an unusual side effect of anti-TNF-alpha treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
AZATHIOPRINE;
BETASONE DIPROPRIONATE;
DERMATOLOGICAL AGENT;
ISONIAZID;
UNCLASSIFIED DRUG;
ADOLESCENT;
CASE REPORT;
CLINICAL FEATURE;
CROHN DISEASE;
DOSE RESPONSE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
LABORATORY TEST;
LETTER;
MORPHEA;
SCLERODERMA;
SKIN BIOPSY;
ADOLESCENT;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
BIOPSY;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
HUMANS;
ROSACEA;
SCLERODERMA, LOCALIZED;
SKIN;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 77952825328
PISSN: 11671122
EISSN: 19524013
Source Type: Journal
DOI: 10.1684/ejd.2010.0946 Document Type: Letter |
Times cited : (23)
|
References (6)
|